4th Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$143,226
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Education EDU

Student Loan Financing and Re-Financing

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Government Accountability Office (GAO); Office of Management & Budget (OMB); White House Office

Medical/Disease Research/Clinical Labs MED

NIH; FDA; Agency for Health Care Quality & Research Funding

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; White House Office; SENATE; Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); White House Office; SENATE; Government Accountability Office (GAO); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Taxation/Internal Revenue Code TAX

Flexible Spending Accounts; Health Savings Accounts

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); White House Office; Centers For Disease Control & Prevention (CDC)

Insurance INS

Health Insurance; Professional Liability Insurance; State Insurance Marketplace

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); White House Office

Health Issues HCR

Medicare Physician Payments Reform, Patient access to care; Graduate Medical Education; Physician Workforce Issues; Health reform implementation (PL 111-148); Telehealth (Health Information Technology)

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); White House Office; Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO)

Budget/Appropriations BUD

Labor HHS Appropriations

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); SENATE; Medicare Payment Advisory Commission (MedPAC); White House Office; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Torts TOR

Professional Liability Insurance; Medical Liability Reform

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); SENATE; Office of Management & Budget (OMB); White House Office; Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP)

Medicare/Medicaid MMM

Graduate Medical Education; Health Care Quality, Patient Access to Health Care; Physician Workforce; Medicare Physician Payment Issues; Independent Payment Advisory Board. H.R. 574, The Medicare Physician Payment Innovation Act of 2013.

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); White House Office; SENATE; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA)

Bills named: H.R. 574 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.